Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Skin disorders in HIV patients have shifted, with more sexually transmitted infections and ART-related conditions now common.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

Certain mutations in the hairless protein disrupt its ability to regulate the hair cycle.

3D models from confocal microscopy improve melanoma detection on sun-damaged skin.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Cronkhite-Canada syndrome can be diagnosed without gastrointestinal polyps if there is severe mucosal atrophy and edema.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.